Endo Health
FDA warns Endo Health on AMS pelvic mesh plant
Endo Health Solutions (NSDQ:ENDP) said the FDA warned it about procedural violations at a Minnesota plant run by its American Medical Systems subsidiary that makes pelvic mesh products.
Medtech legal news for the week of Mar. 10, 2014
State AGs subpoena Endo Health over pelvic mesh products
Endo Health Solutions (NSDQ:ENDP) said its pelvic mesh products are under investigation by the attorneys general from several states including California.
Philly court sets up new pelvic mesh mass tort
A Pennsylvania state judge ordered the creation of a mass tort this week to collect product liability lawsuits filed over pelvic mesh products against some of the largest names in medical devices.
Endo Health takes $500M writedown on American Medical Systems
Endo Health Solutions (NSDQ:ENDP) said today that it plans to write down the value of its American Medical Systems acquisition.
Bard mesh cases slated for discovery
Endo Health to deal HealthTronics for up to $130M
Endo Health Solutions (NSDQ:ENDP) said it’s selling its HealthTronics urology business to Altaris Capital Partners for up to $130 million, including milestones.
The medtech tax will be repealed, and other predictions for 2014
As we put a ribbon on 2013, another tumultuous year for the medical device industry, it’s time to check the tea leaves for what medtech might expect in 2014.
These predictions are based on the 2,500 or so stories we’ve written this year about the medical device space, as well as conversations we’ve had with hundreds of industry leaders about their thoughts, concerns, annoyances and triumphs.
Prediction #1: The medical device tax will not survive 2014